Analytical Data
-
Gene name
MANSC1
- Application
-
Alternative Names
LOH12CR3; Loss of heterozygosity 12 chromosomal region 3 protein
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
Q9H8J5
-
Expression Region
Gln27~Ile431
-
Molecular Weight
48kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MANSC1, or Mansonius somatic C1 protein, is a protein of significant interest in the field of molecular biology and immunology due to its potential role in various biological processes, including cell signaling, immune response, and pathogen recognition. The research surrounding MANSC1 has been fueled by its association with certain diseases and its presence in a variety of tissues, suggesting a multifunctional role in human physiology. Studies have indicated that MANSC1 may interact with specific receptors and adaptors within the immune system, potentially influencing the activation of immune cells and the modulation of inflammatory responses. Moreover, the investigation of recombinant MANSC1 proteins aims to elucidate their structural and functional characteristics, which could pave the way for therapeutic applications, such as vaccine development or targeted immunotherapies. The ability to produce MANSC1 in a recombinant form allows for detailed studies of its biochemical properties and interactions, facilitating a better understanding of its mechanisms of action. As researchers continue to explore the implications of MANSC1 in health and disease, its significance in biomedicine becomes increasingly evident, highlighting the need for further investigation into its potential roles and applications in therapeutic contexts.
